Sacrococcygeal Teratomas in Children and Adolescents - A Danish 26-Year Retrospective Cohort Study

Line Walther Lundbæk Siggaard1, Mark Bremholm Ellebæk2, Lene Gaarsmand Christensen3

  • 1Department of Pediatric Hematology and Oncology, Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.

PubMed

Insights

Sacrococcygeal teratomas (SCTs) occur in 1 in 27,513 births. Long-term, 16% recur, 3% are fatal, and 25% of children face urological or anorectal issues.

Area of Science:

  • Pediatric oncology
  • Developmental biology
  • Surgical oncology

Background:

  • Sacrococcygeal teratomas (SCTs) are congenital tumors.
  • Understanding their incidence and long-term outcomes is crucial for pediatric care.

Purpose of the Study:

  • To determine the incidence of SCTs in children and adolescents in Denmark.
  • To assess the outcomes and long-term sequelae associated with SCTs.
  • To evaluate the risk factors for recurrence and mortality.

Main Methods:

  • Nationwide retrospective register-based cohort study.
  • Inclusion of all Danish children under 18 diagnosed with SCT from 1995-2021.
  • Data combined from four national registries.

Main Results:

  • Sixty-two patients identified; incidence of 1 in 27,513 live births.
  • Tumor types: 48% mature, 34% immature, 18% malignant.
  • Long-term sequelae: 24% urological, 22% anorectal; 16% recurrence rate; 3% SCT-related mortality.

Conclusions:

  • SCT incidence remained stable.
  • Significant rates of recurrence (16%) and long-term sequelae (25% urological/anorectal) observed.
  • SCT-related mortality is 3%.
Abstract